Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Ross

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Hematotherapy|December 1, 1996
Tumor cell contamination of bone marrow harvest products: clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapyB E Brockstein, A A Ross, T J Moss, et al.
Urology|January 1, 1994
Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: correlation to preoperative serum prostate-specific antigenJ W Moul, D J Lewis, A A Ross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
Cytotherapy|April 30, 2010
Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patientsJ M Shammo, S L Smith, M V Bennett, et al.
Acta Endocrinologica|March 1, 1990
Lack of antibody formation during long-term subcutaneous treatment with the somatostatin analogue octreotide in acromegalyP A van Liessum, L M Swinkels, G F Pieters, et al.
Cancer Research|May 1, 1994
Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamideJ Passos-Coelho, A A Ross, J M Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Early tumor cell dissemination in patients with clinically localized carcinoma of the prostateS W Melchior, E Corey, W J Ellis, et al.
Blood|February 15, 1995
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factorJ L Passos-Coelho, A A Ross, T J Moss, et al.
Blood|November 1, 1993
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniquesA A Ross, B W Cooper, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factorJ L Passos-Coelho, A A Ross, D J Kahn, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Hematotherapy|December 1, 1996
Tumor cell contamination of bone marrow harvest products: clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapyB E Brockstein, A A Ross, T J Moss, et al.
Urology|January 1, 1994
Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: correlation to preoperative serum prostate-specific antigenJ W Moul, D J Lewis, A A Ross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
Cytotherapy|April 30, 2010
Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patientsJ M Shammo, S L Smith, M V Bennett, et al.
Acta Endocrinologica|March 1, 1990
Lack of antibody formation during long-term subcutaneous treatment with the somatostatin analogue octreotide in acromegalyP A van Liessum, L M Swinkels, G F Pieters, et al.
Cancer Research|May 1, 1994
Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamideJ Passos-Coelho, A A Ross, J M Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Early tumor cell dissemination in patients with clinically localized carcinoma of the prostateS W Melchior, E Corey, W J Ellis, et al.
Blood|February 15, 1995
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factorJ L Passos-Coelho, A A Ross, T J Moss, et al.
Blood|November 1, 1993
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniquesA A Ross, B W Cooper, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factorJ L Passos-Coelho, A A Ross, D J Kahn, et al.
Pageof 3